Participation institutionnelle et des fonds - Acheteurs
Les principaux détenteurs qui ont ouvert de nouvelles positions dans Bolt Biotherapeutics, Inc. comprennent
Vivo Capital, LLC,
Tang Capital Management Llc,
Sofinnova Investments, Inc.,
Pivotal bioVenture Partners Investment Advisor LLC,
Vanguard Group Inc,
Nan Fung Group Holdings Ltd,
Samsara BioCapital, LLC,
Board of Trustees of The Leland Stanford Junior University,
Pfizer Inc,
Geode Capital Management, Llc,
Renaissance Technologies Llc,
Squarepoint Ops LLC,
ADAR1 Capital Management, LLC,
BlackRock, Inc.,
Morgan Stanley,
GWM Advisors LLC,
Tower Research Capital LLC (TRC),
Bank Of America Corp /de/,
UBS Group AG,
et
Fmr Llc
.
Cette page montre les changements dans la structure de participation en listant les institutions, les fonds et les principaux actionnaires qui ont augmenté leurs avoirs ou ouvert de nouvelles positions au cours de la dernière période de déclaration. Les lignes vertes indiquent les nouvelles positions. Cliquez sur l'icône du lien pour voir l'historique complet des transactions.
Passez au niveau supérieurpour débloquer des données premium.
| Date de dépôt |
Source |
Investisseur |
|
Type |
Prix moyen
(Est) |
Actions |
Δ Actions
(%) |
Valeur déclarée
(1000 $) |
Δ Valeur
(%) |
Allocation de portefeuille
(%) |
| 2025-08-11 |
13F |
Vanguard Group Inc
|
|
|
|
58 484 |
|
341 |
|
|
| 2025-08-14 |
13F |
UBS Group AG
|
|
|
|
183 |
|
1 |
|
|
| 2025-08-11 |
13F |
Pfizer Inc
|
|
|
|
31 305 |
|
181 |
|
|
| 2025-08-13 |
13F |
Nan Fung Group Holdings Ltd
|
|
|
|
58 347 |
|
337 |
|
|
| 2025-08-15 |
13F |
Tower Research Capital LLC (TRC)
|
|
|
|
395 |
|
2 |
|
|
| 2025-08-12 |
13F |
Proequities, Inc.
|
|
|
|
0 |
|
0 |
|
|
| 2025-08-14 |
13F |
ADAR1 Capital Management, LLC
|
|
|
|
10 823 |
|
62 |
|
|
| 2025-08-12 |
13F |
BlackRock, Inc.
|
|
|
|
10 550 |
|
61 |
|
|
| 2025-08-14 |
13F |
Vivo Capital, LLC
|
|
|
|
176 064 |
|
986 |
|
|
| 2025-08-14 |
13F |
Fmr Llc
|
|
|
|
121 |
|
1 |
|
|
| 2025-08-14 |
13F |
GWM Advisors LLC
|
|
|
|
483 |
|
3 |
|
|
| 2025-08-14 |
13F/A |
Barclays Plc
|
|
|
|
6 |
|
0 |
|
|
| 2025-08-14 |
13F |
Samsara BioCapital, LLC
|
|
|
|
52 456 |
|
303 |
|
|
| 2025-07-08 |
13F/A |
Salem Investment Counselors Inc
|
|
|
|
2 |
|
0 |
|
|
| 2025-08-08 |
13F |
SBI Securities Co., Ltd.
|
|
|
|
10 |
|
0 |
|
|
| 2025-08-14 |
13F |
Tang Capital Management Llc
|
|
|
|
166 879 |
|
963 |
|
|
| 2025-08-15 |
13F |
Morgan Stanley
|
|
|
|
3 579 |
|
21 |
|
|
| 2025-08-13 |
13F |
Renaissance Technologies Llc
|
|
|
|
18 325 |
|
106 |
|
|
| 2025-08-27 |
13F/A |
Squarepoint Ops LLC
|
|
|
|
12 388 |
|
72 |
|
|
| 2025-08-14 |
13F |
Bank Of America Corp /de/
|
|
|
|
282 |
|
2 |
|
|
| 2025-07-31 |
13F |
Board of Trustees of The Leland Stanford Junior University
|
|
|
|
35 978 |
|
208 |
|
|
| 2025-08-08 |
13F |
Geode Capital Management, Llc
|
|
|
|
18 533 |
|
108 |
|
|
| 2025-08-12 |
13F |
Jpmorgan Chase & Co
|
|
|
|
43 |
|
0 |
|
|
| 2025-08-14 |
13F |
Sofinnova Investments, Inc.
|
|
|
|
137 721 |
|
795 |
|
|
| 2025-07-24 |
NP |
FCFMX - Fidelity Series Total Market Index Fund
|
|
|
|
33 989 |
14,56 |
11 |
-28,57 |
|
| 2025-08-13 |
13F |
Pivotal bioVenture Partners Investment Advisor LLC
|
|
|
|
94 573 |
|
546 |
|
|
